Urinary tract infection: Traditional pharmacologic therapies

American Journal of Medicine

Volumn 113, Issue 1 SUPPL. 1, 2002, Pages 35-44

  Nicolle, Lindsay E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFDINIR; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; NITROFURANTOIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TOBRAMYCIN; TRIMETHOPRIM;

ALLERGY; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CHOLECYSTITIS; CLINICAL TRIAL; DIARRHEA; DRUG URINE LEVEL; EOSINOPHILIA; GASTROINTESTINAL DISEASE; HUMAN; HYPERSENSITIVITY; LEUKOPENIA; NEPHROTOXICITY; OTOTOXICITY; PHOTOSENSITIVITY; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; THROMBOCYTOSIS; URINARY EXCRETION; URINARY TRACT INFECTION; VESTIBULAR DISORDER;

EID: 0037043286     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(02)01058-6     Document Type: Review

References (42)

1. Antibiotic selection for urinary tract infection: New microbiologic considerations
2. Pivmecillinam in the treatment of urinary tract infections
3. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections
4. Diagnosis and treatment of uncomplicated urinary tract infection
5. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis
6. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
7. The ECO.SENS Project: A prospective, multinational, multicenter epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens. Interim Report
8. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women
9. Urinary tract infection in women: Diagnosis and treatment
10. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial
11. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates
12. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women: Ciprofloxacin Urinary Tract Infection Group
13. A practical guide to the management of complicated urinary tract infection
14. A trial comparing low-dose, short-course ciprofloxacin and standard 7-day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection
15. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection
16. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection
17. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections
18. A comparison between single dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women
19. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection
20. Variations among family physicians' management strategies for lower urinary tract infection in women: A report from the Washington Family Physicians Collaborative Research Network
21. Practice guidelines for urinary tract infection in the era of managed care
22. Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO
23. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women
24. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections
25. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women
26. Urinary tract infections complicating pregnancy
27. Treatment of lower urinary tract infection in pregnancy
28. Correlation of urinary tract infection with urinary screening at the first antepartum visit
29. Infectious disease and perinatal morbidity
30. Urinary tract infections in women
31. Asymptomatic bacteriuria in pregnancy: Maternal and fetal complications
32. Uterine contractions after antibiotic therapy for pyelonephritis in pregnancy
33. Asymptomatic bacteriuria in pregnancy
34. Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis
35. Urinary tract infections complicating pregnancy
36. Urinary tract infections in pregnancy
37. Bacterial urinary tract infections in diabetes
38. Urinary tract infections during pregnancy
39. Effective prophylaxis for recurrent urinary tract infections during pregnancy
40. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women